REDWOOD CITY, CA--(Marketwire - December 04, 2008) - PDL BioPharma, Inc. (NASDAQ: PDLI) today announced the election of David Parkinson, M.D., as a member of the board of directors of Facet Biotech Corporation, the biotechnology company PDL plans to spin off into a separate, publicly-held company, effective on or about December 18, 2008.
